Related Experiment Videos
Pharmacotherapy of pompholyx.
Uwe Wollina1, Mohamed Badawy Abdel Naser
1Academic Teaching Hospital Dresden Friedrichstadt, Department of Dermatology, Friedrichstrasse 41, 01067 Dresden, Germany. wollina-uw@khdf.de
Expert Opinion on Pharmacotherapy
|June 24, 2004
Summary
Pompholyx, a palm and sole skin condition, presents treatment challenges due to skin thickness. Therapies include topical corticosteroids, photochemotherapy, and emerging treatments like botulinum toxin injections.
Area of Science:
- Dermatology
- Inflammatory skin disorders
Background:
- Pompholyx is an inflammatory vesicobullous disorder affecting the palms and soles.
- Treatment is complicated by the thick stratum corneum and numerous sweat glands in the affected skin.
- Current therapies face challenges due to the unique skin characteristics.
Purpose of the Study:
- To review the current therapeutic landscape for pompholyx.
- To highlight the efficacy of various treatment modalities.
- To discuss emerging treatment options for recalcitrant cases.
Main Methods:
- Review of existing literature on pompholyx treatments.
- Analysis of topical and systemic therapeutic approaches.
- Evaluation of photochemotherapy and novel interventions.
Main Results:
- Topical corticosteroids and calcineurin inhibitors are mainstays of treatment.
- Topical photochemotherapy (8-methoxypsoralen) shows efficacy comparable to systemic approaches.
- Systemic therapy is often required for severe (bullous) pompholyx, with corticosteroids being common.
- Combination therapy with immunosuppressants is used for refractory cases.
- Intradermal botulinum toxin is an emerging treatment option.
Conclusions:
- Pompholyx management requires addressing unique skin properties.
- A range of topical, systemic, and phototherapy options exist.
- Novel treatments like botulinum toxin show promise for difficult-to-treat pompholyx.